Diastolic dysfunction in hypertensive heart disease is associated with altered myocardial metabolism

Circulation

Volumn 99, Issue 17, 1999, Pages 2261-2267

  Lamb, Hildo J ^a   Beyerbacht, Hugo P ^a   Van Der Laarse, Arnoud ^a   Stoel, Berend C ^a   Doornbos, Joost ^a   Van Der Wall, Ernst E ^a   De Roos, Albert ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Diastole; Hypertension; Magnetic resonance imaging; Spectroscopy; Stress

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTIHYPERTENSIVE AGENT; ATROPINE; CREATINE PHOSPHATE; DOBUTAMINE; PHOSPHATE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLE; HEART LEFT VENTRICLE MASS; HEART MUSCLE; HEART MUSCLE METABOLISM; HUMAN; HYPERTENSION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; STRESS;

EID: 0032903774     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.17.2261     Document Type: Article

References (40)

1. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The fifth report of the joint national committee on detection, evaluation, and treatment of high blood pressure (JNC V). Arch Intern Med. 1993;153:154-183.
2. Fouad FM, Tarazi RC, Gallagher JH, Macintyre WJ, Cook SA. Abnormal left ventricular relaxation in hypertensive patients. Clin Sci. 1980;59: 411s-414s.
3. Fouad FM, Slominski JM, Tarazi RC. Left ventricular diastolic function in hypertension: relation to left ventricular mass and systolic function. J Am Coll Cardiol. 1984;3:1500-1506.
4. Inouye I, Massie B, Loge D, Topic N, Silverstein D, Simpson P, Tubau J. Abnormal left ventricular filling: an early finding in mild to moderate systemic hypertension. Am J Cardiol. 1984;53:120-126.
5. Smith V, Schulman P, Karimeddini MK, White WB, Meeran MK, Katz AM. Rapid ventricular filling in left ventricular hypertrophy, II: pathologic hypertrophy. J Am Coll Cardiol 1985;5:869-874.
6. Radice M, Albertini A, Alli C, Canciani C, di Tullio M, Manzini M, Mariotti G, Salmoirago E, Taioli E, Zatta G, Tarolo GL. Assessment of ventricular function in arterial hypertension with radionuclide ventriculography. Am J Med. 1988;84:133-135.
7. Ren J, Pancholy SB, Iskandrian AS, Lighty GW, Mallavarapu C, Segal BL. Doppler echocardiographic evaluation of the spectrum of left ventricular diastolic dysfunction in essential hypertension. Am Heart J. 1994; 127:906-913.
8. Schulman DS, Flores AR, Tugoen J, Dianzumba S, Reichek N. Antihypertensive treatment in hypertensive patients with normal left ventricular mass is associated with normal left ventricular remodeling and improved diastolic function. Am J Cardiol. 1996;78:56-60.
9. Miller DD, Walsh RA. In vivo phosphorus-31 NMR spectroscopy of abnormal myocardial high-energy phosphate metabolism during cardiac stress in hypertensive-hypertrophied non-human primates. Int J Card Imaging. 1990-91;6:57-70.
10. Osbakken M, Douglas PS, Ivanics T, Zhang D, Van Winkle T. Creatine kinase kinetics studied by phosphorus-31 nuclear magnetic resonance in a canine model of chronic hypertension-induced cardiac hypertrophy. J Am Call Cardiol. 1992;19:223-228.
11. Zhang J, Merkle H, Hendrich K, Garwood M, From AHL, Ugurbil K, Bache RJ. Bioenergetic abnormalities associated with severe left ventricular hypertrophy. J Clin Invest. 1993;92:993-1003.
12. 31P NMR spectroscopic study. Circulation. 1995;92:1274-1283.
13. Haniala JJ, Mostbeck GH, Foster E, Fujita N, Dulce MC, Chazouilleres AF, Higgins CB. Velocity-encoded cine MRI in the evaluation of left ventricular diastolic function: measurement of mitral valve and pulmonary vein flow velocities and flow volume across the mitral valve. Am Heart J. 1993;125:1054-1066.
14. Pattynama PMT, Lamb HJ, van der Velde EA, van der Wall EE, de Roos A. Left ventricular measurements with cine and spin-echo MR imaging: a study of reproducibility with variance component analysis. Radiology. 1993;187:261-268.
15. Weiss RG, Bottomley PA, Hardy CJ, Gerstenblith G. Regional myocardial metabolism of high-energy phosphates during isometric exercise in patients with coronary artery disease. N Engl J Med. 1990;323: 1593-1600.
16. 31P magnetic resonance spectroscopy. Lancet. 1991;338:973-976.
17. 31P-NMR spectroscopy. NMR Biomed. 1996;9:217-227.
18. 31P-magnetic resonance spectroscopy. J Invest Med. 1997;45:453-462.
19. 31P-MRS. Circulation. 1997;96:2969-2977.
20. Diamond GA, Forrester JS. Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease. N Engl J Med. 1979;300: 1350-1358.
21. Lamb HJ, Doornbos J, van der Velde EA, Kruit MC, Reiber JHC, de Roos A. Echo planar MRI of the heart on a standard system: validation of measurements of left ventricular function and mass. J Comput Assist Tomogr. 1996;20:942-949.
22. Kayser HWM, Schalij MJ, van der Wall EE, Stoel BC, de Roos A. Biventricular function in patients with nonischemic right ventricle tachyarrhythmias assessed with MR imaging. AJR Am J Roentgenol. 1997;169:995-999.
23. Pluim BM, Lamb HJ, Kayser HWM, Leujes F, Beijerbacht HP, Zwinderman AH, van der Laarse A, Vliegen HW, de Roos A, van der Wall EE. Functional and metabolic evaluation of the athlete's heart by magnetic resonance imaging and dobutamine stress magnetic resonance spectroscopy. Circulation. 1998;97:666-672.
24. van der Geest RJ, Buller VGM, Jansen E, Lamb HJ, Baur LHB, van der Wall EE, de Roos A, Reiber JHC. Comparison between manual and semiautomated analysis of left ventricular volume parameters from short-axis MR images. J Comput Assist Tomogr. 1997;21:756-765.
25. Lamb HJ, Singleton RR, van der Geest RJ, Pohost GM, de Roos A. MR imaging of regional cardiac function: low-pass filtering of wall thickness curves. Magn Reson Med. 1995;34:498-502.
26. Ordidge RJ, Connelly A, Lohman JAB. Image-selected in vivo spectroscopy (ISIS): a new technique for spatially selective NMR spectroscopy. J Magn Reson. 1986;66:283-294.
27. van Heugten HAA, de Jonge HW, Bezstarosti K, Sharma HS, Verdouw PD, Lamers JMJ. Intracellular signaling and genetic reprogramming during agonist-induced hypertrophy of cardiomyocytes. Ann N Y Acad Sci. 1995;752:343-352.
28. Granger CB, Karimeddini MK, Smith V, Shapiro HR, Katz AM, Riba AL. Rapid ventricular filling in left ventricular hypertrophy, I: physiologic hypertrophy. J Am Coll Cardiol. 1985;5:862-868.
29. Sadoshima J, Xu Y, Slayter HS, Izumo S. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell. 1993;75:977-984.
30. de Roos A, Doornbos J, Luyten PR, Oostenwaal LJMP, van der Wall EE, den Hollander JA. Cardiac metabolism in patients with dilated and hypertrophic cardiomyopathy: assessment with proton-decoupled P-31 MR spectroscopy. J Magn Reson Imaging. 1992;2:711-719.
31. Massie BM, Schaefer S, Garcia J, McKirnan MD, Schwartz GG, Wisneski JA, Weiner MW, White FC. Myocardial high-energy phosphate and substrate metabolism in swine with moderate left ventricular hypertrophy. Circulation. 1995;91:1814-1823.
32. 403/+ mouse model of familial hypertrophic cardiomyopathy. J Clin Invest. 1998;101:1775-1783.
33. 31P-NMR study on the isolated rat heart. Acta Physiol Scand. 1993;149:311-321.
34. Ingwall JS, Kramer MF, Fifer MA, Lorell BH, Shemin R, Grossman W, Allen PD. The creatine kinase system in normal and diseased human myocardium. N Engl J Med. 1985;313:1050-1054.
35. Bache RJ, Zhang J, Path G, Merkle H, Hendrich K, From AHL, Ugurbil K. High-energy phosphate responses to tachycardia and inotropic stimulation in left ventricular hypertrophy. Am J Physiol. 1994;266: H1959-H1970.
36. Yelamarty RV, Moore RL, Yu FTS, Elensky M, Semanchick AM, Cheung JY. Relaxation abnormalities in single cardiac myocytes from renovascular hypertensive rats. Am J Physiol. 1992;262:C980-C990.
37. Bonow RO, Udelson JE. Left ventricular diastolic dysfunction as a cause of congestive heart failure. Ann Intern Med. 1992;117:502-510.
38. Susie D, Nuñez E, Frohlich ED, Prakash O. Angiotensin II increases left ventricular mass without affecting myosin isoform mRNAs. Hypertension. 1996;28:265-268.
39. Schunkert H, Hense H, Holmer SR, Stender M, Perz S, Keil U, Lorell BH, Riegger GAJ. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med. 1994;330:1634-1638.
40. Fagard R, Staessen J, Thijs L, Amery A. Influence of antihypertensive drugs on exercise capacity. Drugs. 1993;46:32-36.